— Know what they know.
Not Investment Advice

MRZM OTC

Marizyme, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +29900.0% 3Y: -99.7% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $39538 mcap · 86M float · 0.0021% daily turnover · Short 100% of daily vol

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
8
Earnings Quality
22
Growth
48
Value
15
Momentum
50
Safety
0
Cash Flow
30

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-14.62
Distress Zone
Piotroski F-Score
3/9
✗ ✗ ✓ ✓ ✗ ✓ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
7.78
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 12.9/100
Trend: Stable
Earnings Quality
—
OCF/NI: 0.17x
Accruals: -62.8%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MRZM scores -14.62, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MRZM scores 3/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MRZM's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MRZM receives an estimated rating of CCC (score: 12.9/100), with a stable trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.06x
P/B
-0.00x
P/FCF
-1.72x
P/OCF
—
EV/EBITDA
-2.95x
EV/Revenue
180.92x
EV/EBIT
-2.74x
EV/FCF
-8.64x
Earnings Yield
-334.24%
FCF Yield
-58.27%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. MRZM currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.820
EBT / EBIT
×
EBIT Margin
-65.976
EBIT / Rev
×
Asset Turnover
0.006
Rev / Assets
×
Equity Multiplier
-1.552
Assets / Equity
=
ROE
117.5%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MRZM's ROE of 117.5% is driven by Asset Turnover (0.006), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
675.4%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Dr. Steven Brooks,
Chief Medical Officer
$300,000 $— $316,667
Dr. Catherine Pachuk,
Chief Scientific Officer and Executive Vice President
$298,750 $— $298,750
Amy Chandler, Regulatory
cutive Vice President of Regulatory Affairs and Quality Management Systems
$201,826 $— $212,649
James Sapirstein, Interim
Interim Chief Executive Officer
$90,000 $— $203,102
Dr. Neil J.
Campbell, former Chief Executive Officer
$110,214 $— $193,547
Roger Schaller, Commercial
cutive Vice President of Commercial Operations
$165,531 $— $172,970
David Barthel,
Chief Executive Officer
$58,336 $— $58,336
Dr. Vithalbhai Dhaduk,
Chairman and former Interim Chief Executive Officer
$— $— $48,191

CEO Pay Ratio

0:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $203,102
Avg Employee Cost (SGA/emp): $1,551,190
Employees: 11

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
11
-15.4% YoY
Revenue / Employee
$58,710
Rev: $645,810
Profit / Employee
$-6,321,758
NI: $-69,539,336
SGA / Employee
$1,551,190
Avg labor cost proxy
R&D / Employee
$197,885
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
ROE -3.7% -5.1% -5.9% -8.4% -15.9% -23.0% -27.3% -20.3% -24.9% -33.9% -49.3% -49.6% -1.2% -1.1% -2.0% -8.3% -10.2% -31.4% 49.8% 1.2% 1.18%
ROA -3.6% -5.1% -5.8% -8.3% -15.4% -22.4% -26.1% -17.6% -20.5% -27.2% -37.5% -34.3% -72.9% -67.0% -95.3% -1.6% -2.2% -2.3% -1.8% -75.7% -75.72%
ROIC -2.9% -4.1% -4.6% -5.9% -10.5% -14.9% -18.1% -17.4% -16.4% -19.1% -25.0% -25.2% -46.0% -38.5% -41.7% 13.3% -1.7% -2.1% -2.1% -1.9% -1.90%
ROCE -3.7% -5.2% -5.9% -6.7% -12.5% -18.6% -22.4% -17.3% -18.2% -22.9% -30.6% -29.7% -98.9% -1.0% -1.9% 4.7% 65.5% 9.9% 18.0% 1.4% 1.39%
Gross Margin — — — 79.4% 54.8% 58.3% 25.9% 50.7% 2.4% — 82.2% 79.6% 70.9% 69.5% 73.1% 71.9% -77.4% -5.7% — — —
Operating Margin — — — -16.5% -39.2% -38.0% -11.9% -47.2% 47.7% — -74.5% -29.4% -22.4% -16.5% -26.0% -26.8% -148.1% -41.8% — — —
Net Margin — — — -16.5% -39.8% -38.0% -10.2% -43.9% 89.4% — -112.0% -20.4% -246.3% -19.8% -111.4% -178.8% -64.9% -189.5% — — —
EBITDA Margin — — — -13.8% -35.7% -32.4% -10.0% -39.0% 86.7% — -100.0% -7.0% -232.1% -5.0% -37.6% -136.8% -52.1% -56.5% — — —
FCF Margin — — — -8.5% -17.1% -20.1% -14.3% -19.2% -27.5% -58.9% -264.1% -141.0% -46.5% -21.1% -12.6% -8.6% -7.3% -8.1% -11.0% -20.9% -20.93%
OCF Margin — — — -7.5% -16.4% -19.5% -13.9% -19.1% -27.5% -58.9% -264.2% -141.0% -46.5% -21.1% -12.6% -8.6% -7.3% -8.0% -10.8% -20.5% -20.48%
ROA 3Y Avg snapshot only -1.17%
ROIC Economic snapshot only -1.89%
Cash ROA snapshot only -17.67%
Cash ROIC snapshot only -33.97%
CROIC snapshot only -34.73%
NOPAT Margin snapshot only -114.61%
Pretax Margin snapshot only -120.08%
R&D / Revenue snapshot only 7.44%
SGA / Revenue snapshot only 57.61%
SBC / Revenue snapshot only 34.53%
Valuation
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
P/E Ratio -9.95 -17.03 -24.16 -13.58 -12.53 -10.53 -5.36 -4.81 -5.55 -5.29 -5.44 -3.86 -0.57 -0.33 -0.07 -0.13 -0.07 -0.17 -0.14 -0.30 -0.000
P/S Ratio — — — 349.15 371.42 318.08 116.47 125.29 306.24 578.16 2940.41 1018.72 92.45 31.49 7.12 17.06 7.04 21.20 19.54 35.93 0.061
P/B Ratio 0.36 0.88 1.42 0.91 1.62 2.01 1.24 1.07 1.35 1.74 2.66 1.89 1.24 0.75 0.48 -0.46 -0.98 -1.08 -0.76 -0.42 -0.003
P/FCF -92.32 -221.69 -225.23 -40.95 -21.71 -15.85 -8.16 -6.53 -11.13 -9.82 -11.13 -7.22 -1.99 -1.49 -0.57 -1.99 -0.96 -2.61 -1.78 -1.72 -1.716
P/OCF — — — — — — — — — — — — — — — — — — — — —
EV/EBITDA -13.00 -33.36 -78.81 -22.33 -16.66 -12.95 -6.24 -5.62 -5.75 -5.52 -5.94 -4.52 -0.77 -0.64 -0.58 -0.57 -0.62 -0.85 -0.78 -2.95 -2.950
EV/Revenue — — — 307.58 363.38 319.73 119.97 131.11 295.35 567.36 2959.33 1048.35 113.26 52.40 36.26 52.80 38.95 64.05 75.57 180.92 180.921
EV/EBIT -9.95 -17.03 -24.16 -11.96 -12.35 -10.65 -5.55 -5.11 -5.41 -5.34 -5.74 -4.33 -0.75 -0.62 -0.56 -0.56 -0.61 -0.83 -0.76 -2.74 -2.742
EV/FCF -92.32 -221.69 -225.21 -36.08 -21.24 -15.93 -8.41 -6.83 -10.74 -9.63 -11.21 -7.43 -2.44 -2.48 -2.88 -6.17 -5.32 -7.90 -6.88 -8.64 -8.642
Earnings Yield -10.0% -5.9% -4.1% -7.4% -8.0% -9.5% -18.7% -20.8% -18.0% -18.9% -18.4% -25.9% -1.8% -3.0% -14.0% -7.9% -14.4% -5.9% -7.4% -3.3% -3.34%
FCF Yield -1.1% -0.5% -0.4% -2.4% -4.6% -6.3% -12.2% -15.3% -9.0% -10.2% -9.0% -13.8% -50.3% -67.1% -1.8% -50.2% -1.0% -38.2% -56.2% -58.3% -58.27%
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Current Ratio 0.00 0.00 0.01 12.17 4.31 1.31 0.10 0.07 1.40 2.23 1.74 1.46 0.67 0.23 0.05 0.03 0.04 0.03 0.04 0.03 0.029
Quick Ratio 0.00 0.00 0.01 11.82 4.23 1.25 0.09 0.06 1.40 2.22 1.56 1.30 0.60 0.21 0.04 0.02 0.04 0.03 0.04 0.03 0.028
Debt/Equity 0.00 0.00 0.00 0.00 0.03 0.03 0.04 0.05 0.04 0.04 0.07 0.08 0.31 0.52 1.97 -0.98 -4.45 -2.17 -2.18 -1.72 -1.716
Net Debt/Equity -0.00 -0.00 -0.00 -0.11 -0.03 0.01 0.04 0.05 -0.05 -0.03 0.02 0.06 0.28 0.50 1.95 — — — — — —
Debt/Assets 0.00 0.00 0.00 0.00 0.03 0.03 0.03 0.04 0.03 0.03 0.04 0.05 0.14 0.21 0.39 0.58 0.94 1.09 0.95 1.25 1.254
Debt/EBITDA -0.00 -0.00 -0.00 -0.00 -0.31 -0.19 -0.18 -0.25 -0.17 -0.12 -0.15 -0.19 -0.16 -0.27 -0.47 -0.40 -0.52 -0.57 -0.58 -2.37 -2.370
Net Debt/EBITDA 0.00 0.00 0.01 3.02 0.37 -0.07 -0.18 -0.25 0.21 0.10 -0.04 -0.13 -0.14 -0.26 -0.47 -0.39 -0.51 -0.57 -0.58 -2.36 -2.364
Interest Coverage — — — — -127.59 -179.08 -188.14 -73.72 -91.03 -34.04 -20.22 -10.89 -12.68 -7.26 -1.82 -2.34 -1.36 -1.29 -1.60 -0.74 -0.738
Equity Multiplier 1.01 1.01 1.02 1.01 1.04 1.04 1.07 1.33 1.38 1.44 1.56 1.56 2.22 2.51 5.09 -1.68 -4.72 -1.99 -2.30 -1.37 -1.368
Cash Ratio snapshot only 0.002
Debt Service Coverage snapshot only -0.686
Cash to Debt snapshot only 0.002
FCF to Debt snapshot only -0.144
Defensive Interval snapshot only 1.4 days
Efficiency & Turnover
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.006
Inventory Turnover — — — 6.13 18.79 3.99 24.89 2.27 6.53 14.49 2.30 2.44 2.22 0.97 0.65 0.96 3.38 6.12 9.12 14.61 14.612
Receivables Turnover — — — 2.69 9.71 15.15 7.24 3.64 8.54 6.14 0.43 1.01 4.84 8.35 7.70 12.13 8.72 9.64 6.71 8.11 8.113
Payables Turnover 1.51 2.88 1.44 1.84 1.78 0.21 0.25 0.43 0.29 0.69 0.36 0.49 0.20 0.07 0.10 0.11 0.24 0.26 0.29 0.33 0.334
DSO — — — 136 38 24 50 100 43 59 842 361 75 44 47 30 42 38 54 45 45.0 days
DIO 0 0 0 60 19 91 15 161 56 25 159 150 164 375 564 381 108 60 40 25 25.0 days
DPO 241 127 253 198 206 1721 1445 858 1274 531 1017 746 1858 5256 3666 3249 1543 1387 1275 1093 1092.9 days
Cash Conversion Cycle — — — -3 -149 -1606 -1380 -597 -1175 -446 -16 -235 -1618 -4838 -3055 -2838 -1394 -1289 -1180 -1023 -1023.0 days
Fixed Asset Turnover snapshot only 0.230
Operating Cycle snapshot only 70.0 days
Cash Velocity snapshot only 2.878
Capital Intensity snapshot only 115.891
Growth (YoY)
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue -1.0% -1.0% 1.0% 42.7% — — — 1.8% 6.7% -49.7% -91.4% -77.9% 11.0% 1.7% 12.0% 6.8% 1.8% 51.7% -24.8% -69.0% -68.96%
Net Income -3.2% -4.8% -2.9% -2.7% -4.6% -4.6% -4.7% -1.8% -98.4% -82.2% -1.2% -1.2% -2.3% -1.3% -1.4% -2.9% -71.2% -99.5% -8.8% 72.2% 72.17%
EPS 18.4% -4.8% -2.9% -1.5% -2.8% -2.1% -2.2% -1.3% -59.7% -61.1% -89.3% -97.7% -1.9% -1.3% -1.3% -2.5% -53.3% 38.3% 64.3% 90.3% 90.33%
FCF 48.8% 43.0% 39.5% -3.8% -29.1% -47.5% -33.6% -5.2% -71.5% -47.6% -60.1% -62.5% -87.6% 4.6% 38.0% 52.9% 56.4% 41.8% 34.4% 24.1% 24.07%
EBITDA -2.2% -2.0% -20.9% -1.0% -4.4% -8.0% -15.3% -3.7% -1.5% -1.1% -1.2% -1.2% -2.2% -1.1% -63.1% -2.1% -16.6% -40.3% -16.9% 79.4% 79.41%
Op. Income -3.3% -4.4% -2.8% -2.7% -4.5% -4.6% -4.8% -1.9% -62.5% -30.3% -38.2% -47.9% -37.7% -4.8% 14.9% -1.2% -1.6% -2.0% -1.7% -90.9% -90.91%
OCF Growth snapshot only 25.73%
Asset Growth snapshot only -42.43%
Debt Growth snapshot only 23.44%
Shares Change snapshot only 1.88%
Growth (CAGR)
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue 3Y — — — -15.6% 31.3% 51.9% 66.8% 87.2% 1.2% 1.1% — — — — — 67.8% 48.5% 26.6% -5.5% -18.9% -18.92%
Revenue 5Y — — — -64.6% -61.5% -56.9% -49.3% -46.6% -13.7% -18.3% -32.0% -18.2% 21.8% 36.2% 39.1% 62.3% 100.0% 1.1% — — —
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — 3.9% — — — — — — — — — — — — — — —
Gross Profit 5Y — — — — — -54.7% -49.2% -48.0% — — — — — 1.8% — — 3.6% — — — —
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y 1.1% 1.1% 1.1% 1.5% 1.6% 1.5% 1.8% 23.2% 32.1% 31.5% 31.0% 30.6% 10.6% 10.2% 8.9% -8.7% -22.4% -21.5% -20.8% -26.5% -26.48%
Assets 5Y -15.1% -10.2% -10.2% 0.5% 14.3% 41.3% 40.5% 46.6% 85.0% 84.9% 84.7% 83.5% 68.8% 69.0% 77.9% 5.2% -5.1% -5.5% -5.5% -5.8% -5.77%
Equity 3Y 1.2% 1.2% 1.2% 1.6% 1.8% 1.7% 1.7% 12.1% 18.6% 16.7% 13.3% 12.8% -15.0% -18.6% -36.4% — — — — — —
Book Value 3Y -16.4% -17.2% -17.5% -13.6% -7.7% -15.4% -15.4% -64.9% -43.7% -8.3% -11.0% -11.3% -33.0% -35.9% -50.7% — — — — — —
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Revenue Stability 0.67 0.67 0.67 0.67 0.66 0.65 0.64 0.63 0.16 0.12 0.01 0.00 0.54 0.50 0.28 0.48 0.74 0.80 0.36 0.22 0.225
Earnings Stability 0.56 0.40 0.17 0.03 0.16 0.39 0.43 0.66 0.64 0.68 0.67 0.71 0.68 0.78 0.76 0.64 0.82 0.83 0.91 0.40 0.401
Margin Stability 0.00 0.00 0.12 0.00 0.00 0.00 0.12 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Rev. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.96 0.50 0.500
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend 0.10 0.10 0.12 -0.04 -0.11 -0.16 -0.19 -0.17 -0.16 -0.21 -0.34 -0.35 -2.00 -2.01 -6.28 — — — — — —
Gross Margin Trend — — — — — — — — — — — -1.99 0.82 1.50 4.36 2.14 0.55 0.66 2.44 -2.74 -2.740
FCF Margin Trend — — — — — — — — — — — -127.14 -24.17 18.36 126.59 71.55 29.67 31.91 127.36 53.85 53.847
Sustainable Growth Rate — — — — — — — — — — — — — — — — — — — — —
Internal Growth Rate — — — — — — — — — — — — — — — — — — — — —
Cash Flow Quality
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
OCF/Net Income 0.11 0.08 0.11 0.29 0.55 0.65 0.64 0.74 0.50 0.54 0.49 0.53 0.28 0.22 0.13 0.06 0.07 0.06 0.07 0.17 0.171
FCF/OCF 1.00 1.00 1.00 1.14 1.05 1.03 1.02 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.02 1.02 1.02 1.022
FCF/Net Income snapshot only 0.174
CapEx/Revenue — — — 1.0% 75.4% 55.9% 34.4% 5.3% 1.3% 4.1% 7.4% 3.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
CapEx/Depreciation snapshot only 0.000
Accruals Ratio -0.03 -0.05 -0.05 -0.06 -0.07 -0.08 -0.09 -0.05 -0.10 -0.13 -0.19 -0.16 -0.52 -0.52 -0.83 -1.47 -2.00 -2.16 -1.66 -0.63 -0.628
Sloan Accruals snapshot only 0.597
Cash Flow Adequacy snapshot only -938983.000
Dividends & Buybacks
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — — — — — —
FCF Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Total Payout Ratio — — — — — — — — — — — — — — — — — — — — —
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% -13.9% -8.3% -7.1% -12.1% -0.0% 0.0% -4.3% -3.1% -4.4% -45.9% -57.0% -2.0% -67.1% -17.0% -6.6% -7.1% -7.7% -7.68%
Total Shareholder Return 0.0% 0.0% 0.0% -13.9% -8.3% -7.1% -12.1% -0.0% 0.0% -4.3% -3.1% -4.4% -45.9% -57.0% -2.0% -67.1% -17.0% -6.6% -7.1% -7.7% -7.68%
DuPont Factors
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Tax Burden (NI/EBT) 0.98 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.02 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.03 1.05 1.09 1.08 1.14 1.55 1.43 1.59 1.63 1.45 1.82 1.820
EBIT Margin — — — -25.72 -29.42 -30.02 -21.62 -25.68 -54.56 -106.26 -515.25 -241.96 -151.51 -83.89 -64.21 -93.87 -63.64 -76.97 -99.44 -65.98 -65.976
Asset Turnover 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.02 0.01 0.01 0.006
Equity Multiplier 1.01 1.01 1.01 1.01 1.03 1.03 1.05 1.16 1.22 1.24 1.31 1.44 1.61 1.71 2.08 5.30 4.76 13.60 -27.73 -1.55 -1.552
Per Share
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
EPS (Diluted TTM) $-0.05 $-0.07 $-0.08 $-0.11 $-0.20 $-0.23 $-0.26 $-0.25 $-0.32 $-0.37 $-0.49 $-0.49 $-0.94 $-0.85 $-1.12 $-1.73 $-1.44 $-0.52 $-0.40 $-0.17 $-0.17
Book Value/Share $1.43 $1.42 $1.41 $1.64 $1.55 $1.19 $1.13 $1.12 $1.31 $1.11 $1.01 $1.00 $0.43 $0.37 $0.17 $-0.48 $-0.10 $-0.08 $-0.07 $-0.12 $-0.15
Tangible Book/Share $-0.01 $-0.02 $-0.02 $0.18 $0.10 $0.02 $-0.03 $-0.32 $-0.34 $-0.36 $-0.45 $-0.45 $-0.43 $-0.48 $-0.63 $-1.23 $-0.54 $-0.23 $-0.22 $-0.27 $-0.27
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.01 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.01 $0.01 $0.01 $0.01 $0.01 $0.00 $0.00 $0.00 $0.01
FCF/Share $-0.01 $-0.01 $-0.01 $-0.04 $-0.12 $-0.15 $-0.17 $-0.18 $-0.16 $-0.20 $-0.24 $-0.26 $-0.27 $-0.19 $-0.14 $-0.11 $-0.10 $-0.03 $-0.03 $-0.03 $-0.10
OCF/Share $-0.01 $-0.01 $-0.01 $-0.03 $-0.11 $-0.15 $-0.17 $-0.18 $-0.16 $-0.20 $-0.24 $-0.26 $-0.27 $-0.19 $-0.14 $-0.11 $-0.10 $-0.03 $-0.03 $-0.03 $-0.10
Cash/Share $0.00 $0.00 $0.00 $0.18 $0.10 $0.02 $0.00 $0.00 $0.11 $0.08 $0.05 $0.03 $0.01 $0.01 $0.00 $0.01 $0.00 $0.00 $0.00 $0.00 $0.00
EBITDA/Share $-0.04 $-0.04 $-0.03 $-0.06 $-0.15 $-0.19 $-0.23 $-0.22 $-0.30 $-0.35 $-0.46 $-0.43 $-0.85 $-0.73 $-0.70 $-1.19 $-0.89 $-0.31 $-0.27 $-0.09 $-0.09
Debt/Share $0.00 $0.00 $0.00 $0.00 $0.04 $0.04 $0.04 $0.06 $0.05 $0.04 $0.07 $0.08 $0.13 $0.19 $0.33 $0.47 $0.46 $0.18 $0.16 $0.20 $0.20
Net Debt/Share $-0.00 $-0.00 $-0.00 $-0.18 $-0.05 $0.01 $0.04 $0.06 $-0.06 $-0.04 $0.02 $0.06 $0.12 $0.19 $0.33 $0.46 $0.45 $0.18 $0.16 $0.20 $0.20
Academic Models
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — -14.624
Altman Z-Prime snapshot only -38.747
Piotroski F-Score 1 1 2 3 3 3 3 2 2 3 3 3 2 2 2 2 2 2 1 3 3
Beneish M-Score — — — — — — — -0.90 — — -4.30 -2.90 — — -6.53 -11.34 -16.95 -18.09 — — —
Ohlson O-Score snapshot only 7.779
Net-Net WC snapshot only $-0.27
EVA snapshot only $-22126186.59
Credit
Metric Trend Q4'19 Q1'20 Q2'20 Q3'20 Q4'20 Q1'21 Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Current
Credit Rating snapshot only CCC
Credit Score 81.53 81.95 58.79 89.00 61.34 53.78 46.58 21.33 29.33 35.47 34.31 25.60 18.72 16.43 12.75 12.74 12.73 12.84 12.75 12.88 12.875
Credit Grade snapshot only 17
Credit Trend snapshot only 0.134
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 1
Sector Credit Rank snapshot only 1

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms